Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- Data from GARNET study indicates robust activity of dostarlimab in patients with advanced or recurrent endometrial cancer
- ViiV Healthcare presents positive, 48-week data from two pivotal phase III studies showing long-acting, injectable two-drug regimen of cabotegravir and rilpivirine has similar efficacy to daily, three-drug oral treatment in adults living with HIV-1 infection
- GSK receives a positive CHMP opinion for intravenous zanamivir for the treatment of complicated influenza
Tweets from GSK
-
GSK @GSK
#Today TESARO, an oncology-focused business acquired by GSK, presented preliminary data at SGO from the ongoing Phase 1/2 study in women with recurrent or advanced endometrial cancer.
about 12 hours ago
-
GSK @GSK
#DYK no two cancers are the same? That’s why our #oncology scientists continue to explore new treatment methods so we can transform the future of cancer treatment for patients.
about 17 hours ago -
GSK @GSK
More than 40 of our intrepid colleagues are in Ethiopia this week to trek up to the 4,500m summit of Ra Dashen in support of @savechildrenuk. Follow us on Instagram to get all the action: gsk.to/2JjD5j4
about 19 hours ago
